- Home
- ALAR vs INMB Comparison
ALAR vs INMB Comparison
Compare ALAR & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- INMB
- Stock Information
- Founded
- ALAR 2013
- INMB 2015
- Country
- ALAR Israel
- INMB United States
- Employees
- ALAR N/A
- INMB N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- INMB Health Care
- Exchange
- ALAR Nasdaq
- INMB Nasdaq
- Market Cap
- ALAR 94.0M
- INMB 109.9M
- IPO Year
- ALAR 2018
- INMB 2019
- Fundamental
- Price
- ALAR $13.20
- INMB $4.76
- Analyst Decision
- ALAR Strong Buy
- INMB Strong Buy
- Analyst Count
- ALAR 2
- INMB 2
- Target Price
- ALAR $25.50
- INMB $21.00
- AVG Volume (30 Days)
- ALAR 245.7K
- INMB 254.8K
- Earning Date
- ALAR 11-25-2024
- INMB 10-31-2024
- Dividend Yield
- ALAR N/A
- INMB N/A
- EPS Growth
- ALAR N/A
- INMB N/A
- EPS
- ALAR 0.07
- INMB N/A
- Revenue
- ALAR $31,117,000.00
- INMB $42,000.00
- Revenue This Year
- ALAR $22.15
- INMB N/A
- Revenue Next Year
- ALAR $11.59
- INMB N/A
- P/E Ratio
- ALAR $21.41
- INMB N/A
- Revenue Growth
- ALAR 52.26
- INMB N/A
- 52 Week Low
- ALAR $4.20
- INMB $4.45
- 52 Week High
- ALAR $46.69
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- ALAR 43.35
- INMB 36.74
- Support Level
- ALAR $12.05
- INMB $4.45
- Resistance Level
- ALAR $16.07
- INMB $6.26
- Average True Range (ATR)
- ALAR 1.24
- INMB 0.31
- MACD
- ALAR -0.25
- INMB -0.17
- Stochastic Oscillator
- ALAR 13.81
- INMB 14.49
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.